Padmanabh P. Bhatt
Technik-/Wissenschafts-/F&E-Leiter bei SUPERNUS PHARMACEUTICALS, INC.
Vermögen: 251 187 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Padmanabh P. Bhatt
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 35 | |
| Public Company | Pharmaceuticals: Major | 27 | |
Dow Silicones Corp.
 Dow Silicones Corp. Chemicals: SpecialtyProcess Industries Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI.
5
| Joint Venture | Chemicals: Specialty | 5 |
Hercon Laboratories Corp.
1
| Private Company | 1 | |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD.
1
| Extinct | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Padmanabh P. Bhatt
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| DURECT CORPORATION | Pharmaceuticals: Major | Founder Founder | |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Director/Board Member General Counsel | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Executive Officer Chief Executive Officer Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Sales & Marketing | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Founder Private Equity Investor | |
| East Tennessee State University | College/University | Masters Business Admin Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree | |
| San Jose State University | College/University | Undergraduate Degree Masters Business Admin | |
| Santa Clara University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| University of Vermont | College/University | Doctorate Degree Undergraduate Degree | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Director/Board Member Founder | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel General Counsel Sales & Marketing Sales & Marketing | |
| Licensing Executives Society | Corporate Officer/Principal Corporate Officer/Principal | ||
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer President General Counsel Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistik
International
| Vereinigte Staaten | 49 |
| Belgien | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 19 |
| Commercial Services | 2 |
| Finance | 2 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 231 |
| Corporate Officer/Principal | 180 |
| Independent Dir/Board Member | 65 |
| Undergraduate Degree | 65 |
| Chairman | 54 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Georges Gemayel | 33 |
| Charles Newhall | 29 |
| Samuel Saks | 28 |
| Michael Bigham | 27 |
| Phyllis Gardner | 19 |
| Bruce Cozadd | 19 |
| Krisztina Zsebo | 17 |
| Matthew Fust | 16 |
| Michael Bart Sheffery | 16 |
| Jack Khattar | 16 |
| John Siebert | 16 |
| Barbara Finck | 15 |
| James W. Young | 15 |
| Ed F. Schnipper | 15 |
- Börse
- Insiders
- Padmanabh P. Bhatt
- Unternehmensverbindungen
